Exclusive: Eyeing big Covid-19 testing expansion, Ginkgo rolls out 50M rapid antigen diagnostics

In what they hope will be a key part of an extensive effort to boost Covid-19 testing in the US, Ginkgo Bioworks is acquiring and distributing 50 million rapid antigen tests that can potentially be used for virus surveillance in schools and communities and for quick, on the ground diagnoses.